LHC Group Stock Price, News & Analysis (NASDAQ:LHCG)

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) posted its quarterly earnings data on Wednesday, August, 7th. The health services provider reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.06. The health services provider had revenue of $517.84 million for the quarter, compared to the consensus estimate of $524.24 million. LHC Group had a return on equity of 8.83% and a net margin of 4.20%. LHC Group's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.84 EPS. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for LHC Group.

LHC Group issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $4.25 to $4.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.31. The company issued revenue guidance of $2.09-2.14 billion, compared to the consensus revenue estimate of $2.11 billion.

10 brokerages have issued 1-year price targets for LHC Group's shares. Their predictions range from $114.00 to $146.00. On average, they anticipate LHC Group's stock price to reach $130.67 in the next twelve months. This suggests a possible upside of 12.1% from the stock's current price. View Analyst Price Targets for LHC Group.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

News articles about LHCG stock have been trending somewhat negative on Saturday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LHC Group earned a news sentiment score of -1.5 on InfoTrie's scale. They also assigned news stories about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for LHC Group.

LHC Group saw a decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,860,000 shares, a decrease of 7.0% from the August 30th total of 2,000,000 shares. Based on an average daily volume of 220,100 shares, the days-to-cover ratio is presently 8.5 days. Approximately 6.3% of the shares of the stock are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Chemed (CHE), Amedisys (AMED), Addus Homecare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Visa (V), Cisco Systems (CSCO), Chevron (CVX), Verizon Communications (VZ), Johnson & Johnson (JNJ), Okta (OKTA), Alibaba Group (BABA), CVS Health (CVS) and Exxon Mobil (XOM).

LHC Group's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Tributary Capital Management LLC (0.88%), Summit Creek Advisors LLC (0.51%), Copper Rock Capital Partners LLC (0.48%), Scout Investments Inc. (0.29%), Envestnet Asset Management Inc. (0.11%) and State of Alaska Department of Revenue (0.07%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, Scout Investments Inc. and Envestnet Asset Management Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.

LHCG stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, State of Alaska Department of Revenue, Summit Creek Advisors LLC, Tuttle Tactical Management, Redhawk Wealth Advisors Inc., NEXT Financial Group Inc and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $116.53.

LHC Group has a market capitalization of $3.67 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]